Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Jan 31, 2024	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-24-008807.pdf 0001104659-24-008807.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jan 31, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-24-000010.pdf 0001883850-24-000010.xls
Jan 30, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001000275-24-000005.pdf 0001000275-24-000005.xls
Jan 25, 2024	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000019617-24-000154.pdf 0000019617-24-000154.xls
Jan 25, 2024	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000019617-24-000143.pdf 0000019617-24-000143.xls
Jan 25, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000042.pdf 0001968202-24-000042.xls
Jan 25, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000040.pdf 0001968202-24-000040.xls
Jan 25, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000041.pdf 0001968202-24-000041.xls
Jan 25, 2024	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001086364-24-003704.pdf
Jan 23, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-24-000420.pdf

Data provided by Kaleidoscope.

Investors & Media